Evidence map›Paper›PMID 42755003›Full record

ArticleThe Korean journal of helicobacter and upper gastrointestinal research2026

The Evolution of Autoimmune Gastritis Research (1995-2025): A Hybrid Bibliometric-Conceptual Synthesis.

Yong Hwan Ahn

Abstract read
In one paragraph

Article in The Korean journal of helicobacter and upper gastrointestinal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Autoimmune Gastritis: An Evolving Entity.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yong Hwan AhnDepartment of Internal Medicine, The Manjok Hospital, Bucheon, Korea. autogastritis@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Autoimmune gastritis (AIG) has evolved from a condition primarily recognized in the context of pernicious anemia (PA) to a clinically recognized immune-mediated gastric disease with important neoplastic implications. We investigated the structural and conceptual evolution of AIG research from 1995 to 2025 using a hybrid bibliometric-conceptual approach. Methods: Publications were retrieved from the Web of Science Core Collection. After excluding retracted records and duplicates, 1298 articles and reviews were included. Bibliometric indicators were calculated, and collaboration networks, keyword co-occurrence, temporal evolution, and reference co-citation were analyzed using Gephi, VOSviewer, and CiteSpace. Results: Annual publication output increased from 24 articles in 1995 to 86 articles in 2025, with accelerated growth after 2015. A total of 5608 authors from 45 countries contributed to the literature, with major collaborative networks centered on Europe and North America. Early research focused primarily on PA, gastric autoimmunity, and chronic gastritis. Recent studies have emphasized endoscopic recognition, biomarker-based diagnosis, gastric neuroendocrine tumors, and neoplastic risk assessment. Co-citation analysis further demonstrated a shift from immunologic and pathophysiologic investigations to clinically oriented disease recognition and surveillance-related research. Conclusions: AIG research has undergone a substantial conceptual transition over the past three decades. Contemporary research recognizes AIG as a distinct gastric disease entity that requires earlier diagnosis, risk stratification, and surveillance-oriented management.

Indexed as

Autoimmune diseasesBibliometric analysisGastric neoplasmsGastritisHelicobacter pylori

Identifiers

PMID42755003
PMCPMC13586466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.